We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$7.75B
AUM Growth
+$180M
Cap. Flow
-$55.1M
Cap. Flow %
-0.71%
Top 10 Hldgs %
15.53%
Holding
560
New
192
Increased
91
Reduced
96
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Industrials 15.13%
3 Healthcare 14.64%
4 Financials 8.83%
5 Consumer Discretionary 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQDA icon
401
Liquidia Corp
LQDA
$8.02B
$535K 0.01%
66,836
-1,439
-2% -$13.5K
CYRX icon
402
CryoPort
CYRX
$762M
$531K 0.01%
+28,976
New +$460K
EQ icon
403
Equillium
EQ
$133M
$517K 0.01%
+91,260
New +$574K
TEX icon
404
Terex
TEX
$7.74B
$491K 0.01%
+15,638
New +$480K
TREX icon
405
Trex
TREX
$5.01B
$486K 0.01%
13,558
-13,948
-51% -$473K
KNX icon
406
Knight Transportation
KNX
$11.4B
$478K 0.01%
+14,558
New +$465K
TSM icon
407
TSMC
TSM
$2.18T
$473K 0.01%
12,067
-251,422
-95% -$10.3M
VRML
408
DELISTED
Vermillion, Inc.
VRML
$445K 0.01%
+500,219
New +$580K
SWK icon
409
Stanley Black & Decker
SWK
$15.7B
$433K 0.01%
+2,994
New +$422K
KDMN
410
CALL
DELISTED
Kadmon Holdings, Inc.
KDMN
$412K 0.01%
200,000
GMS
411
DELISTED
GMS Inc
GMS
$391K 0.01%
+17,756
New +$319K
KZR
412
DELISTED
Kezar Life Sciences
KZR
$377K ﹤0.01%
+4,895
New +$761K
IART icon
413
Integra LifeSciences
IART
$1.34B
$369K ﹤0.01%
+6,600
New +$340K
ACRS icon
414
Aclaris Therapeutics
ACRS
$869M
$366K ﹤0.01%
+167,208
New +$911K
LMT icon
415
Lockheed Martin
LMT
$136B
$346K ﹤0.01%
+952
New +$318K
HTGM
416
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$339K ﹤0.01%
1,134
-1,585
-58% -$661K
SM icon
417
SM Energy
SM
$6.87B
$337K ﹤0.01%
26,942
-1,366,471
-98% -$19.8M
AHCO icon
418
CALL
AdaptHealth
AHCO
$759M
$275K ﹤0.01%
250,001
PTN
419
CALL
Palatin Technologies
PTN
$13.8M
$213K ﹤0.01%
147
-226
-61% -$356K
APVO icon
420
Aptevo Therapeutics
APVO
$5.21M
0
PSTL
421
Postal Realty Trust
PSTL
$699M
$167K ﹤0.01%
+10,572
New +$166K
GEVO icon
422
CALL
Gevo
GEVO
$382M
$137K ﹤0.01%
69,589
NE
423
DELISTED
Noble Corporation
NE
$130K ﹤0.01%
+69,541
New +$164K
NTBL
424
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$108K ﹤0.01%
2,381
RMTI icon
425
Rockwell Medical
RMTI
$28.2M
$81K ﹤0.01%
+245
New +$124K

Similar funds

Alyeska Investment Group's Q2 2019 Portfolio in Review

As of Q2 2019, Alyeska Investment Group held 560 positions worth $7.75B, up 2.4% from $7.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group's Q2 2019 filing shows 192 new, 91 increased, 96 reduced and 133 closed positions. Its largest new stake was Uber: 2,870,924 shares worth $133M. The largest sale was Intel, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Alyeska Investment Group's largest Q2 2019 buy was Uber: 2,870,924 shares worth $133M.
  • Alyeska Investment Group added most to NXP Semiconductors in Q2 2019, an estimated $91M increase.
  • Alyeska Investment Group's biggest Q2 2019 reduction was Activision Blizzard, cutting an estimated $64.8M.
  • Alyeska Investment Group fully exited Intel in Q2 2019, selling an estimated $143M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $7.75B portfolio in Q2 2019.
  • Alyeska Investment Group opened 192 new positions and closed 133 in Q2 2019.
  • Alyeska Investment Group's portfolio value rose 2.4% quarter-over-quarter to $7.75B.

Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.